Two neuraminidase inhibitors for treatment of influenza
Article Abstract:
The FDA has approved zanamivir for the treatment of influenza. Sold under the trade name Relenza, it inhibits a viral enzyme called neuraminidase. This in turn decreases viral shedding. It comes in the form of dry powder and is inhaled through the mouth using a Diskhaler much like the treatment of asthma. Studies have shown it can prevent influenza in those exposed to it and decreases symptoms. The FDA will probably also approve oseltamivir, which will be sold under the trade name Tamiflu.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Influenza vaccine, 1999-2000
Article Abstract:
A new influenza vaccine is available for the 1999-2000 flu season. It contains the antigens A/Beijing/262/95-like (H1N1), A/Sydney/5/97-like (H3N2), and B/Yamanashi/166/98. It is recommended for the elderly and patients at high risk of contracting the flu and everyone who comes in contact with them. Health care personnel should also be vaccinated. The best time to vaccinate is from October through mid-November.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Problems with influenza vaccine
Article Abstract:
There may be a shortage of influenza vaccine in the US this winter. Until adequate supplies are available, only elderly patients, high-risk patients, and their contacts should be vaccinated.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Clinical manifestations and treatment of dysfunctional uterine bleeding. Clinical Features and Treatment of Peristomal Pyoderma Gangrenosum
- Abstracts: Sex and urinary tract infections. Human metapneumovirus--an important new respiratory virus. Asymptomatic bacteriuria -- important or not?